drugset / Trial / NCT01297036

Pharmacokinetic Comparisons of Two Donepezil Formulations

NCT01297036

RandomizedCrossoverOpen-label

Summary

To compare the relative bioavailability and pharmacokinetic characteristics of a newly developed donepezil formulation with a conventional formulation in healthy subjects with a single dose, randomized, open-label, 2-sequence -2period crossover study.

Timeline

Start
2008-01
Primary completion
2008-03
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg Oral

Indications